Global Minimally Invasive Gastrointestinal Surgical Systems Market: 12 Countries Analysis - Analysis and Forecast, 2021-2031

Report Highlights

Global Minimally Invasive Gastrointestinal Surgical Systems Market to Reach $10.4 Billion by 2031.

Market Report Coverage - Minimally Invasive Gastrointestinal Surgical Systems

Market Segmentation

• Product Type – Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)[Endoscopes and Endoscopy Systems, Videoscopes, Endoscopic Ultrasound, Therapeutic Energy Devices], Surgical Robotics (Robotic Systems, Robotic Surgery Instruments and Accessories, Services)
• Surgery – Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, Hernia Repair
• End User – Conventional Technologies (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Surgical Robotics (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)

Regional Segmentation

• North America: U.S. and Canada
• Europe: Germany, U.K, Italy, Spain, France, and Rest-of-Europe
• Asia-Pacific: Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
• Rest-of-the-World

Growth Drivers

• Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures
• Availability of Technological Advanced Products in the Field of GI Surgical Procedures
• Increasing Healthcare Spending
• Growth in Robotics GI Surgical Procedures

Market Challenges

• High Cost of Minimally Invasive GI Surgical Procedures
• Shortage of Skilled Professionals
• Restrictive Reimbursement Framework

Market Opportunities

• Development of Long-Distance Teleoperated Surgical Robotic Systems
• Mergers and Acquisitions to Diversify Endoscopic Portfolio
• Investment for Regional Expansions

Key Companies Profiled

Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc.

Key Questions Answered in this Report:

• What is the current market size and future potential of these products?
• What is the current market share and growth share of the different products in the market?
• What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive gastrointestinal surgical systems?
• What are the major market drivers, restraints, and opportunities in the global minimally invasive gastrointestinal surgical systems market?
• What is the impact of the COVID-19 pandemic on the market?
• Which technology is being researched and worked upon to improve the gastrointestinal surgical systems?
• Who are the leading players dominating the global minimally invasive gastrointestinal surgical systems market?
• What are the key development and strategies incorporated by the players of global minimally invasive gastrointestinal surgical systems market, to sustain the competition and retain their supremacy?
• Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive gastrointestinal surgical systems market?
• How advanced technologies such as surgical robotics is gaining traction in terms of market share in in gastrointestinal space?

Overview on the Global Minimally Invasive Gastrointestinal Surgical Systems Market

The global minimally invasive gastrointestinal surgical systems market is currently witnessing a significant change in the market landscape. There is rising investment in the development of healthcare infrastructure, increasing evidence for efficient and promising results in surgery assistance. Thus, this is leading to potential growth opportunities for the minimally invasive gastrointestinal surgical systems market. Moreover, there is an extensive entry of emerging players developing MIS surgical systems. All these predominant factors have led to a significant rise in sales of minimally invasive gastrointestinal surgical systems across the globe.

Global Minimally Invasive Gastrointestinal Surgical Systems Market (2020-2031)

The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031, growing at a CAGR of 6.8% during the forecast period 2021-2031. The increasing complexities in clinical decision-making, rising radiologist workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting the market growth. These challenges include the shortage of skilled professionals, high cost of minimally invasive GI surgical procedures, and restrictive reimbursement framework. Hence, it is anticipated that these trends will have a significant impact on the minimally invasive gastrointestinal surgical systems market in the during the forecast period, and the market will grow multifold.